December 13, 2021 Gamida Cell Presents Two-Year Survival Data for GDA-201 and Resource Utilization Analysis for Omidubicel at 63rd ASH Annual Meeting View Article
December 2, 2021 Chemomab Announces FDA Clearance of Its IND Application for CM-101, a First-In-Class CCL24 Neutralizing Antibody for the Treatment of Primary Sclerosing Cholangitis View Article
November 23, 2021 DiaSorin announces the launch of the first automated test to distinguish between bacterial and viral infections in partnership with MeMed View Article
November 23, 2021 DiaSorin announces the launch of the first automated test to distinguish between bacterial and viral infections in partnership with MeMed View Article
November 18, 2021 PolyPid Announces 500th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ in Abdominal Surgery View Article
November 16, 2021 Yotpo Named 2021 Most Innovative Partner Program by Partnership Leaders View Article
November 3, 2021 Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®) View Article
October 25, 2021 Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Primary Objective View Article
October 21, 2021 Trax Announces Appointment of New Chief Financial Officer and First Independent Board Member View Article
